Physician profile
Vanitha Singaram
NPI 1306065578
$824.36
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $247 · 2020: $95.87 · 2021: $38.91 · 2022: $44.37 · 2023: $35.88 · 2024: $362.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $397.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $121.12 | 2024 | |
| Amgen INC. | $92.44 | 2019-2024 | Evenity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $90.44 | 2024 | Jardiance |
| Novo Nordisk INC | $80.93 | 2019-2023 | |
| Vivus LLC | $78.61 | 2024 | Qsymia |
| Abbott Laboratories | $62.31 | 2019-2023 | |
| Antares Pharma, INC. | $55.76 | 2019 | |
| Medtronic, INC. | $44.37 | 2022 | |
| Lilly USA, LLC | $34.07 | 2019-2020 | |
| Nevro Corp. | $26.11 | 2021 | |
| Insulet Corporation | $21.84 | 2019 | |
| Horizon Therapeutics Plc | $18.90 | 2019 | |
| Companion Medical, INC. | $18.13 | 2020 | |
| Tandem Diabetes Care, INC. | $16.12 | 2020 | |
| Janssen Pharmaceuticals, INC | $15.54 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $14.07 | 2020 | |
| Shire North American Group INC | $12.53 | 2019 | |
| Topcon Healthcare Solutions, INC. | $10.57 | 2019 | |
| Ascensia Diabetes Care US INC. | $10.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vanitha Singaram listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.